Nutrition and lifestyle counseling and healthy behaviors should be the patients and clinicians foundation to maximize overall benefits and cost-effectiveness of GLP-1s for obesity
The best time to take retatrutide guide explores both approaches
American Family Physician, 69 (8), 19611968
As an investigational drug, dosing protocols are strictly controlled within clinical settings and should not be replicated outside of supervised trials
As T2D is often associated with having a high body mass index, one would be forgiven for assuming that the needs of people who use GLP-1s for weight loss and those using it to treat diabetes would be very similar, but recent market research suggests a number of significant differences:5 The majority of people using GLP-1s for weight loss are in their 30s to 50s (often as part of a wider strategy to be proactive about their health), whereas those using GLP-1s for diabetes control are more likely to be over 60
Sometimes GLP-1s that are approved for type 2 diabetes can be prescribed off-label for weight loss
